Great West Life Assurance CO Vertex Pharmaceuticals Inc Transaction History

Great West Life Assurance CO

  • $58 Billion
  • Q4 2024

A detailed history of Great West Life Assurance CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 269,878 shares of VRTX stock, worth $136 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
269,878
Previous 318,281 15.21%
Holding current value
$136 Million
Previous $148 Million 26.71%
% of portfolio
0.19%
Previous 0.26%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$396.64 - $516.74 $19.2 Million - $25 Million
-48,403 Reduced 15.21%
269,878 $109 Million
Q3 2024

Nov 13, 2024
SELL
$460.0 - $505.78 $921,380 - $1.01 Million
-2,003 Reduced 0.63%
318,281 $148 Million
Q2 2024

Aug 12, 2024
BUY
$392.81 - $485.53 $19.7 Million - $24.3 Million
50,062 Added 18.53%
320,284 $150 Million
Q1 2024

May 13, 2024
SELL
$407.69 - $446.08 $3.39 Million - $3.71 Million
-8,327 Reduced 2.99%
270,222 $113 Million
Q4 2023

Feb 13, 2024
SELL
$343.0 - $410.68 $1.74 Million - $2.09 Million
-5,077 Reduced 1.79%
278,549 $113 Million
Q3 2023

Nov 14, 2023
BUY
$338.18 - $362.46 $946,227 - $1.01 Million
2,798 Added 1.0%
283,626 $98.6 Million
Q2 2023

Aug 10, 2023
BUY
$314.42 - $351.91 $2.25 Million - $2.52 Million
7,171 Added 2.62%
280,828 $99.3 Million
Q1 2023

May 12, 2023
SELL
$283.23 - $323.1 $1.32 Million - $1.51 Million
-4,667 Reduced 1.68%
273,657 $86.3 Million
Q4 2022

Feb 10, 2023
SELL
$285.76 - $321.48 $5.69 Million - $6.4 Million
-19,914 Reduced 6.68%
278,324 $80.7 Million
Q3 2022

Nov 01, 2022
BUY
$273.83 - $305.53 $81.7 Million - $91.1 Million
298,238 New
298,238 $86.2 Million
Q2 2022

Aug 09, 2022
SELL
$234.96 - $292.55 $23.7 Million - $29.5 Million
-100,839 Reduced 25.19%
299,457 $84.5 Million
Q1 2022

May 12, 2022
SELL
$221.42 - $260.97 $1.18 Million - $1.39 Million
-5,326 Reduced 1.31%
400,296 $110 Million
Q4 2021

Feb 14, 2022
BUY
$177.01 - $223.45 $2.84 Million - $3.58 Million
16,035 Added 4.12%
405,622 $88.8 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $183,385 - $205,222
1,011 Added 0.26%
389,587 $71.1 Million
Q2 2021

Aug 11, 2021
BUY
$187.49 - $221.1 $19.4 Million - $22.9 Million
103,524 Added 36.32%
388,576 $78.3 Million
Q1 2021

May 17, 2021
SELL
$207.02 - $241.31 $11 Million - $12.9 Million
-53,337 Reduced 15.76%
285,052 $60.9 Million
Q4 2020

Feb 16, 2021
BUY
$207.01 - $276.09 $4.84 Million - $6.46 Million
23,385 Added 7.42%
338,389 $79.8 Million
Q3 2020

Nov 17, 2020
SELL
$255.65 - $303.1 $15.5 Million - $18.4 Million
-60,736 Reduced 16.16%
315,004 $85.7 Million
Q3 2020

Nov 13, 2020
BUY
$255.65 - $303.1 $22.1 Million - $26.1 Million
86,271 Added 29.8%
375,740 $102 Million
Q2 2020

Aug 17, 2020
BUY
$225.48 - $295.8 $5.8 Million - $7.62 Million
25,745 Added 9.76%
289,469 $83.7 Million
Q1 2020

May 14, 2020
SELL
$199.77 - $247.81 $1.75 Million - $2.17 Million
-8,772 Reduced 3.22%
263,724 $63.1 Million
Q4 2019

Feb 11, 2020
BUY
$166.71 - $223.91 $7.87 Million - $10.6 Million
47,230 Added 20.97%
272,496 $59.7 Million
Q3 2019

Oct 25, 2019
SELL
$166.23 - $187.09 $561,026 - $631,428
-3,375 Reduced 1.48%
225,266 $38.2 Million
Q2 2019

Jul 31, 2019
BUY
$164.61 - $190.37 $1.69 Million - $1.96 Million
10,286 Added 4.71%
228,641 $0
Q1 2019

May 08, 2019
BUY
$163.73 - $194.7 $4.52 Million - $5.38 Million
27,628 Added 14.49%
218,355 $40.1 Million
Q4 2018

Feb 12, 2019
SELL
$151.91 - $192.21 $309,136 - $391,147
-2,035 Reduced 1.06%
190,727 $30.4 Million
Q3 2018

Nov 13, 2018
SELL
$167.73 - $192.74 $3.91 Million - $4.49 Million
-23,318 Reduced 10.79%
192,762 $37.2 Million
Q2 2018

Aug 10, 2018
BUY
$145.72 - $169.96 $297,705 - $347,228
2,043 Added 0.95%
216,080 $36.8 Million
Q1 2018

May 10, 2018
SELL
$151.6 - $177.13 $1.05 Million - $1.23 Million
-6,948 Reduced 3.14%
214,037 $34.9 Million
Q4 2017

Feb 09, 2018
BUY
$137.28 - $155.55 $213,470 - $241,880
1,555 Added 0.71%
220,985 $33.1 Million
Q3 2017

Nov 09, 2017
BUY
$148.13 - $162.24 $32.5 Million - $35.6 Million
219,430
219,430 $32.9 Million

Others Institutions Holding VRTX

# of Institutions
1,764
Shares Held
228M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $130B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email